Prevalence, correlates, and impact of sleep disturbance in Chinese meningioma patients
- PMID: 34458943
- DOI: 10.1007/s00520-021-06504-2
Prevalence, correlates, and impact of sleep disturbance in Chinese meningioma patients
Abstract
Purpose: Sleep disturbance is common in meningioma patients and may lead to disease aggravation and decreases health-related quality of life (HRQoL). However, the sleep quality of meningioma patients newly diagnosed and ready for surgery has not been well clarified in China. This study aims to evaluate the prevalence, correlates, and impact of sleep disturbance among Chinese meningioma patients.
Methods: In this cross-sectional study, meningioma patients were recruited from the Affiliated Hospital of Nantong University from January 2020 to November 2020. A series of questionnaires were applied: the 0-10 Numerical Rating Scale (NRS), the Hospital Anxiety and Depression Scale (HADS), the Multidimensional Fatigue Inventory (MFI-20), the Epworth Sleepiness Scale (ESS), the Short-Form 36 (SF-36), the Pittsburgh Sleep Quality Index (PSQI). Independent samples t test, Mann-Whitney U test, chi-square analysis, Pearson/Spearman correlation, and binary logistic regression were used to analyze the data.
Results: One hundred meningioma patients completed the questionnaires. Sleep disturbance affected 43% of the meningioma patients and was linked to many concomitant symptoms, such as headache, fatigue, anxiety, and depression. Binary logistic regression indicated that fatigue and headache were independently associated with sleep disturbance of meningioma patients. Meanwhile, severe sleep disturbance led to lower quality of life.
Conclusions: These findings demonstrated that a considerable number of meningioma patients newly diagnosed and ready for surgery suffered from sleep disturbance, potentially contributing to impair HRQoL. Medical personnel should pay more attention to meningioma patients with sleep disturbance and take effective measures to improve sleep quality, with the ultimate goal to improve their HRQoL.
Keywords: Fatigue; Headache; Meningioma; Quality of life; Sleep quality.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Multidimensional fatigue in Chinese patients with newly diagnosed meningiomas: Prevalence, severity and associated factors.Neuropsychol Rehabil. 2023 Oct;33(9):1564-1581. doi: 10.1080/09602011.2022.2115518. Epub 2022 Sep 3. Neuropsychol Rehabil. 2023. PMID: 36059235
-
Fatigue and contributing factors in Chinese patients with ankylosing spondylitis.Clin Rheumatol. 2020 Aug;39(8):2337-2344. doi: 10.1007/s10067-020-04976-x. Epub 2020 Mar 5. Clin Rheumatol. 2020. PMID: 32133565
-
Sleep quality in Chinese patients with rheumatoid arthritis: contributing factors and effects on health-related quality of life.Health Qual Life Outcomes. 2016 Nov 16;14(1):151. doi: 10.1186/s12955-016-0550-3. Health Qual Life Outcomes. 2016. PMID: 27852301 Free PMC article.
-
Impaired health-related quality of life in meningioma patients-a systematic review.Neuro Oncol. 2017 Jul 1;19(7):897-907. doi: 10.1093/neuonc/now250. Neuro Oncol. 2017. PMID: 28039363 Free PMC article. Review.
-
Health-related quality of life of cranial WHO grade I meningioma patients: are current questionnaires relevant?Acta Neurochir (Wien). 2017 Nov;159(11):2149-2159. doi: 10.1007/s00701-017-3332-8. Epub 2017 Sep 27. Acta Neurochir (Wien). 2017. PMID: 28952044 Free PMC article. Review.
Cited by
-
Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.Support Care Cancer. 2022 Feb;30(2):1765-1773. doi: 10.1007/s00520-021-06585-z. Epub 2021 Oct 1. Support Care Cancer. 2022. PMID: 34595605
-
Chemotherapy and peripheral neuropathy.Neurol Sci. 2021 Oct;42(10):4109-4121. doi: 10.1007/s10072-021-05576-6. Epub 2021 Aug 26. Neurol Sci. 2021. PMID: 34436727 Review.
-
Stigma and related influencing factors in brain cancer patients: a cross-sectional study and parallel mediation analysis.Support Care Cancer. 2024 Jul 17;32(8):522. doi: 10.1007/s00520-024-08731-9. Support Care Cancer. 2024. PMID: 39017733
References
-
- Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol 18(suppl_5):v1–v75. https://doi.org/10.1093/neuonc/now207 - DOI - PubMed - PMC
-
- Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas Lancet 363(9420):1535–1543. https://doi.org/10.1016/S0140-6736(04)16153-9 - DOI - PubMed
-
- Englot DJ, Chang EF, Vecht CJ (2016) Epilepsy and brain tumors. Handb Clin Neurol 134:267–285. https://doi.org/10.1016/B978-0-12-802997-8.00016-5 - DOI - PubMed - PMC
-
- Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168. https://doi.org/10.1016/S1474-4422(04)00680-5 - DOI - PubMed
-
- Waagemans ML, van Nieuwenhuizen D, Dijkstra M, Wumkes M, Dirven CM, Leenstra S, Reijneveld JC, Klein M, Stalpers LJ (2011) Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery 69(1):72–78. https://doi.org/10.1227/NEU.0b013e318212badb (discussion 78–79) - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical